[In the Media] NCD Alliance Japan: How is COVID-19 affecting people living with NCDs?
date : 4/24/2020
Tags: NCDs
![[In the Media] NCD Alliance Japan: How is COVID-19 affecting people living with NCDs?](https://hgpi.org/en/wp-content/uploads/sites/2/49f5e714f4df7dcb7dc75b974e6e4f8f.jpg)
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus in 2019. With the spread of COVID-19 infections all over the world, the impact of COVID-19 on people living with non-communicable diseases (NCDs) including cancer, diabetes, cardiovascular diseases, chronic respiratory disease, mental health has been reported.
- The evidence from multiple countries at the epicentre of the pandemic clearly shows that people living with NCDs are more vulnerable to COVID-19. According to a study, the overall death rate from COVID-19 has been estimated at 0.66%, rising sharply to 7.8% in people aged over 80. *1
- Diabetes, cardiovascular disease, and chronic respiratory disease are the most common underlying diseases of hospitalized patients infected with COVID-19. It has also been pointed out that risk factors common to NCDs, such as smoking, are one of the factors that may aggravate COVID-19. World Health Organization warns that smokers likely face more severe symptoms if infected, leading to hospitalizations and premature deaths.
- Due to the limitation of daily life from self-quarantine and self-isolation, people living with NCDs are more likely to face difficulties with controlling their symptoms and taking medication as they may refrain from going to medical institutions because of fear of COVID-19 infection, and tend to have more stress than healthy people.
- NCDs involve many social determinants such as poverty and education. These social determinants of health are also obstacles to containment of COVID-19, and it is necessary to cultivate awareness and build a foundation for tackling it throughout society.
NCD Alliance Japan, a collaborative platform for civil society operated by Health Global Policy Institute, will do our best to raise our voices for the rights of people living with NCDs, older people and marginalised groups, and to collate and share information useful for COVID-19 infection prevention and control through a NCDs lens.
WHO: Information note on COVID-19 and NCDs (Published 23 March 2020)
https://www.who.int/who-documents-detail/covid-19-and-ncds
For more information about the NCD Alliance Japan, please visit us here:
https://ncdjapan.org/en/
*1: Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020 Mar 30
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Publication Report] The Child Health Project Publishes Family Mental Health Booklet “Learning and Practicing at Home – Stress Management for Children with Intellectual Disabilities” (February 3, 2025)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”